These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 25826088)
1. Paxillin promotes colorectal tumor invasion and poor patient outcomes via ERK-mediated stabilization of Bcl-2 protein by phosphorylation at Serine 87. Huang CC; Wu DW; Lin PL; Lee H Oncotarget; 2015 Apr; 6(11):8698-708. PubMed ID: 25826088 [TBL] [Abstract][Full Text] [Related]
2. Bcl-2 stabilization by paxillin confers 5-fluorouracil resistance in colorectal cancer. Wu DW; Huang CC; Chang SW; Chen TH; Lee H Cell Death Differ; 2015 May; 22(5):779-89. PubMed ID: 25323586 [TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of paxillin confers cisplatin resistance in non-small cell lung cancer via activating ERK-mediated Bcl-2 expression. Wu DW; Wu TC; Wu JY; Cheng YW; Chen YC; Lee MC; Chen CY; Lee H Oncogene; 2014 Aug; 33(35):4385-95. PubMed ID: 24096476 [TBL] [Abstract][Full Text] [Related]
4. Paxillin is positively correlated with the clinicopathological factors of colorectal cancer, and knockdown of Paxillin improves sensitivity to cetuximab in colorectal cancer cells. Du C; Wang X; Zhang J; Liu X; Zhu J; Liu Y Oncol Rep; 2016 Jan; 35(1):409-17. PubMed ID: 26530439 [TBL] [Abstract][Full Text] [Related]
5. Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting. Wu DW; Cheng YW; Wang J; Chen CY; Lee H Cancer Res; 2010 Dec; 70(24):10392-401. PubMed ID: 21159652 [TBL] [Abstract][Full Text] [Related]
6. Paxillin knockdown suppresses metastasis and epithelial‑mesenchymal transition in colorectal cancer via the ERK signalling pathway. Wen L; Zhang X; Zhang J; Chen S; Ma Y; Hu J; Yue T; Wang J; Zhu J; Wu T; Wang X Oncol Rep; 2020 Sep; 44(3):1105-1115. PubMed ID: 32705241 [TBL] [Abstract][Full Text] [Related]
7. Phosphatase of regenerating liver-3 promotes migration and invasion by upregulating matrix metalloproteinases-7 in human colorectal cancer cells. Lee SK; Han YM; Yun J; Lee CW; Shin DS; Ha YR; Kim J; Koh JS; Hong SH; Han DC; Kwon BM Int J Cancer; 2012 Aug; 131(3):E190-203. PubMed ID: 22131018 [TBL] [Abstract][Full Text] [Related]
8. Paxillin promotes tumor progression and predicts survival and relapse in oral cavity squamous cell carcinoma by microRNA-218 targeting. Wu DW; Chuang CY; Lin WL; Sung WW; Cheng YW; Lee H Carcinogenesis; 2014 Aug; 35(8):1823-9. PubMed ID: 24894864 [TBL] [Abstract][Full Text] [Related]
9. Loss of SMAD4 Promotes Lung Metastasis of Colorectal Cancer by Accumulation of CCR1+ Tumor-Associated Neutrophils through CCL15-CCR1 Axis. Yamamoto T; Kawada K; Itatani Y; Inamoto S; Okamura R; Iwamoto M; Miyamoto E; Chen-Yoshikawa TF; Hirai H; Hasegawa S; Date H; Taketo MM; Sakai Y Clin Cancer Res; 2017 Feb; 23(3):833-844. PubMed ID: 27492974 [TBL] [Abstract][Full Text] [Related]
10. [Abnormal expression of APRIL in colorectal cancer cells promotes tumor growth and metastasis]. Wang GH; Lu MH; Wang JC; Wang F; Ding WF; Wang YG; Ju SQ; Wang HM Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):249-55. PubMed ID: 23985251 [TBL] [Abstract][Full Text] [Related]
11. Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9. Dong QZ; Wang Y; Tang ZP; Fu L; Li QC; Wang ED; Wang EH Am J Pathol; 2013 Mar; 182(3):954-64. PubMed ID: 23306155 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus X protein promotes tumor invasion and poor prognosis in hepatocellular carcinoma via phosphorylation of paxillin at Serine 178 by activation of the c-Jun NH2-terminal kinase. Chen MJ; Wu DW; Shen CJ; Cheng YM; Wu CC; Lee H Am J Cancer Res; 2020; 10(1):275-283. PubMed ID: 32064167 [TBL] [Abstract][Full Text] [Related]
13. Effect of Paxillin Expression and Phosphorylation on Colorectal Cancer Prognosis and Metastasis. Zheng H; Tsunedomi R; Xu M; Zhang Y; Kishi H; Kobayashi S; Tomochika S; Nakajima M; Matsui H; Tokumitsu Y; Shindo Y; Iida M; Ioka T; Nagano H Anticancer Res; 2024 Feb; 44(2):511-520. PubMed ID: 38307570 [TBL] [Abstract][Full Text] [Related]
14. Absence of CD9 enhances adhesion-dependent morphologic differentiation, survival, and matrix metalloproteinase-2 production in small cell lung cancer cells. Saito Y; Tachibana I; Takeda Y; Yamane H; He P; Suzuki M; Minami S; Kijima T; Yoshida M; Kumagai T; Osaki T; Kawase I Cancer Res; 2006 Oct; 66(19):9557-65. PubMed ID: 17018612 [TBL] [Abstract][Full Text] [Related]
15. PBX3 promotes migration and invasion of colorectal cancer cells via activation of MAPK/ERK signaling pathway. Han HB; Gu J; Ji DB; Li ZW; Zhang Y; Zhao W; Wang LM; Zhang ZQ World J Gastroenterol; 2014 Dec; 20(48):18260-70. PubMed ID: 25561793 [TBL] [Abstract][Full Text] [Related]
16. Bcl-2 promotes invasion and lung metastasis by inducing matrix metalloproteinase-2. Choi J; Choi K; Benveniste EN; Rho SB; Hong YS; Lee JH; Kim J; Park K Cancer Res; 2005 Jul; 65(13):5554-60. PubMed ID: 15994927 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of growth, migration and invasion of human bladder cancer cells by antrocin, a sesquiterpene lactone isolated from Antrodia cinnamomea, and its molecular mechanisms. Chiu KY; Wu CC; Chia CH; Hsu SL; Tzeng YM Cancer Lett; 2016 Apr; 373(2):174-84. PubMed ID: 26679052 [TBL] [Abstract][Full Text] [Related]
18. RNA interference suppression of A100A4 reduces the growth and metastatic phenotype of human renal cancer cells via NF-kB-dependent MMP-2 and bcl-2 pathway. Yang XC; Wang X; Luo L; Dong DH; Yu QC; Wang XS; Zhao K Eur Rev Med Pharmacol Sci; 2013 Jun; 17(12):1669-80. PubMed ID: 23832737 [TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase 2 promotes cell growth and invasion in colorectal cancer. Dong W; Li H; Zhang Y; Yang H; Guo M; Li L; Liu T Acta Biochim Biophys Sin (Shanghai); 2011 Nov; 43(11):840-8. PubMed ID: 21968416 [TBL] [Abstract][Full Text] [Related]
20. RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo. Cao XX; Xu JD; Xu JW; Liu XL; Cheng YY; Wang WJ; Li QQ; Chen Q; Xu ZD; Liu XP Breast Cancer Res Treat; 2010 Sep; 123(2):375-86. PubMed ID: 19946739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]